EGFR and neoplasm: Activated EGFR signaling can also recruit or reprogram suppressive immunocytes, inhibit major histocompatibility complex (MHC) molecule levels, and upregulate inhibitory cytokines and metabolites, which induces the immunosuppressive tumor microenvironment (TME) [23].